Clinical & translational oncology

• 

  Año 2025, Vol. 27, Número 8

  • REVIEW ARTICLE

    • The role of tumor types in immune-related adverse events

      Qian Hu, Jing Hu, Yan Wang, Zhaohui Wang

      • Resumen

      págs. 3247-3260

      

    • Progress in understanding the regulatory mechanisms of immune checkpoint proteins PD-1 and PD-L1 expression

      Xuanxuan Wu, Zengjun Zhu, Jian Zhang, Maojin Tian, Peiqing Zhao

      • Resumen

      págs. 3261-3271

      

    • Genetic predisposition to polyposis syndromes

      Natalia García Simón, Fátima Valentín Gómez

      • Resumen

      págs. 3272-3284

      

    • CCL20 in the tumor microenvironment: implications for cancer progression and therapeutic approaches

      Louis Boafo Kwantwi, James Danquah Boafo, Bevelyn Emefa Egleh, Mingfeng Li

      • Resumen

      págs. 3285-3292

      

  • CLINICAL GUIDES IN ONCOLOGY

    • SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025)

      Teresa Macarulla Mercadé, Jorge Adeva, Maria Teresa Cano Osuna, Ana Ruiz Casado, Ana María Jiménez Gordo, Ángela Lamarca Lete, Ana María López Muñoz, Roberto Pazo Cid, Tamara Saurí Nadal, Javier Gallego Plazas

      • Resumen

      págs. 3293-3306

      

  • SPECIAL ARTICLE

    • Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish ‘Cambados annual meeting’

      Ignacio Peláez Fernández, Martin Lázaro Quintela, Daniel Adolfo Pérez Fentes, Emilio Esteban González, Enrique Gallardo-Díaz, Carlos Álvarez Fernández, Pablo Álvarez Rodríguez, Urbano Anido Herranz, Cristina Azpitarte Raposeiras, Ángel Máximino Castro Iglesias, Ovidio Fernández Calvo, Natalia Fernández Núñez, Alicia Folgar Torres, Carme García Lorenzo, Aránzazu González del Alba, María José Méndez Vidal, Aurea Molina Díaz, Ignacio Rodríguez Gómez, Sergio Vázquez Estévez

      • Resumen

      págs. 3307-3324

      

  • RESEARCH ARTICLE

    • Efficacy and safety of S-ketamine in pain management for breast cancer patients undergoing modified radical mastectomy: a meta-analysis of randomized controlled trials

      Bilal Abu Hussein, Amr Elrosasy, Haidy Samy, Ali Ahmed Said, Said Samir Alijla, Ahmad Naoras Bitar, Ibrahim Gamal

      • Resumen

      págs. 3325-3339

      

    • Reliability of core needle biopsy for HER2-low early-stage breast cancer

      C. M. Ciniselli, P. Verderio, V. Duroni, P. Baili, S. Pizzamiglio, F. de Braud, S. Folli, C. Depretto, G. Scaperrotta, M.C. De Santis, M. G. Carnevale, C. De Marco, A. Vingiani, G. Pruneri, S. Di Cosimo

      • Resumen

      págs. 3340-3345

      

    • Identification of a novel hypermethylation marker, ZSCAN18, and construction of a diagnostic model in cervical cancer

      Jinhao Yang, Shuang Chen, Yuqing Liu, Ping Wang, Jing Zhao, Jianying Yi, Jin Wei Zhao, Rong Wang

      • Resumen

      págs. 3346-3363

      

    • A PET/CT-based 3D deep learning model for predicting spread through air spaces in stage I lung adenocarcinoma

      Cheng Zheng, Yujie Cai, Jiangfeng Miao, BingShu Zheng, Yan Gao, Chen Shen, ShanLei Bao, ZhongHua Tan, ChunFeng Sun

      • Resumen

      págs. 3364-3374

      

    • Budget impact analysis of neoadjuvant nivolumab for non-small cell lung cancer in the Chilean public healthcare system: An exploratory economic assessment

      Daniela Paredes Fernández, Rony Lenz Alcayaga, Francisco Orlandi Jorquera

      • Resumen

      págs. 3375-3385

      

    • Two inflammation-related genes model could predict risk in prognosis of patients with lung adenocarcinoma

      Wei Yang, Junqi Long, Gege Li, Jiashuai Xu, Yining Chen, Shijie Zhou, Zhidong Liu, Shuangtao Zhao

      • Resumen

      págs. 3386-3398

      

    • New evidence for miRNA testing in head and neck squamous cell cancer patients

      Blanca Pilar Galindo Torres, Raquel Alcaraz Ortega, Patricia Saiz López, María Isabel Adiego Leza, María del Mar Moradillo Renuncio, Carlos García Girón, Miguel Grijalba Uche

      • Resumen

      págs. 3399-3409

      

    • A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994–2018

      J. Rubió Casadevall, Jan Trallero, Carla Calvo, Montserrat Puigdemont-Guinart, M. Carulla, Arantza Sanvisens, A. Ameijide, Anna Vidal, Clàudia Pla, Jordi Marruecos Querol, Rafael Marcos Gragera, Jaume Galceran Padrós

      • Resumen

      págs. 3410-3420

      

    • Management and outcome of children with high-risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease

      Blanca Martínez de las Heras, P.M. Rubio Aparicio, Alba Rubio San Simón, Lucas Moreno, Paula Mazorra, Ricardo López Almaraz, Mercedes L. Llempén López, Julia Balaguer Guill, Vanessa Segura, M. Bermúdez Cortés, Irene Jiménez, Désirée Ramal, María Adela Cañete Nieto

      • Resumen

      págs. 3421-3431

      

    • Diffuse large B-cell lymphoma: examining evolving patterns in mortality, incidence, and demographics

      Silpa Choday, Eric Tran, Miguel González

      • Resumen

      págs. 3432-3438

      

    • Exploratory biomarker analysis from a phase III study of the PI3K inhibitor, copanlisib, in combination with rituximab in patients with indolent non-Hodgkin lymphoma, a retrospective study

      Shalini Chaturvedi, Anke Weispfenning, Tine Descamps, Sara Bellinvia, David Bauer, Rong Du, Teresa Lunt, Lidia Mongay Soler, Barrett H. Childs, Pier Luigi Zinzani

      • Resumen

      págs. 3439-3448

      

    • Clinical implications of Alu-based cell-free DNA and serum onco-piRNA monitoring in colorectal cancer management

      Mohammad Taghizadeh Teymorloei, Vahid Jafarlou, Somaieh Matin, Mortaza Raeisi, Yousef Roosta, Sima Mansouri Derakhshani, Abbas Ali Hosseinpour Feizi, Abbas Karimi

      • Resumen

      págs. 3449-3457

      

    • Efficacy of transarterial chemoembolization combined with radiofrequency ablation in the treatment of liver metastases from colorectal cancer

      Junwei Yin, Yongli Zhao, Junping Yin, Shanshan Yang

      • Resumen

      págs. 3458-3464

      

    • Cabazitaxel versus abiraterone or enzalutamide for metastatic castration-resistant prostate cancer following docetaxel failure: a systematic review and meta-analysis

      Izael Pereira da Silva, Lucas Guimarães Campos Roriz de Amorim, Gabriel Vieira Piredda, Marcelo Mass-Lindenbaum, Francisco Cezar Aquino de Moraes, Pedro F. S. Freitas, Bárbara Vieira Lima Aguiar Melão, Helisandro Montenegro Brandão, Karine Martins da Trindade

      • Resumen

      págs. 3465-3476

      

    • Patterns of failure after stereotactic body radiotherapy to non-spine bone metastases

      Héctor Pérez Montero, Alicia Lozano, Rodolfo De Blas Piñol, Javier Hernández, Arantxa Mera, Ferrán Guedea Edo, Arturo Navarro Martín

      • Resumen

      págs. 3477-3484

      

    • USP14 targets FABP5-mediated ferroptosis to promote proliferation and cisplatin resistance of HNSCC

      Jiaxin Qian, Zitong Zhao, Liying Ma, Wensheng Liu, Yongmei Song

      • Resumen

      págs. 3485-3500

      

    • Dendritic cell immunotherapy has its antitumor action improved by the LPS in the maturation process

      Angela Maria Moed Lopes, Jéssica Ferreira Vieira, Saulo Fernando Moreira da Silva, Eddie Fernando Candido Murta, Márcia Antoniazi Michelin

      • Resumen

      págs. 3501-3510

      

    • HPV-driven cancer: from epidemiology to the HPV-driven tumor board proposal, everything you wanted to know but were afraid to ask

      Daniela Alterio, Michał Gola, Mattia Zaffaroni, Maria Giulia Vincini, Carlo Guglielmo Cattaneo, Cynthia Aristei, Gabriella Macchia, Vitaliana De Sanctis, Francesca DeFelice

      • Resumen

      págs. 3511-3529

      

  • BRIEF RESEARCH ARTICLE

    • Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2− breast cancer

      João Queirós Coelho, Beatriz Lau, Rita Pichel, Laura Guerra, Hugo Miranda, Raquel Romão, Maria João Sousa, Fernando Gonçalves, Joana Simões Pereira, Sérgio Xavier Azevedo, António Araújo

      • Resumen

      págs. 3530-3534

      

    • Evaluating the benefits of immunotherapy in metastatic cervical cancer: an observational retrospective analysis

      Ana Isabel Martin Quesada, Lina I. Pérez Méndez, Natalia Dolores Pérez Rodríguez

      • Resumen

      págs. 3535-3542

      

    • Burnout levels among radiation oncology residents in Spain: a cross-sectional survey

      Elías Gomis Sellés, María Mingarro de León, Angel Montero, Meritxell Arenas Prat

      • Resumen

      págs. 3543-3549

      

    • Clinical metric of tumor mutational burden depicts colorectal cancer patients at the extremes

      Ming Zheng

      • Resumen

      págs. 3550-3554

      

  • Correction

    • Correction: Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2− breast cancer

      João Queirós Coelho, Beatriz Lau, Rita Pichel, Laura Guerra, Hugo Miranda, Raquel Romão, Maria João Sousa, Fernando Gonçalves, Joana Simões Pereira, Sérgio Xavier Azevedo, António Araújo

      págs. 3555-3556

      

    • Correction: Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish ‘Cambados annual meeting’

      Ignacio Peláez Fernández, Martin Lázaro Quintela, Daniel Adolfo Pérez Fentes, Emilio Esteban González, Enrique Gallardo-Díaz, Carlos Álvarez Fernández, Pablo Álvarez Rodríguez, Urbano Anido Herranz, Cristina Azpitarte Raposeiras, Ángel Máximino Castro Iglesias, Ovidio Fernández Calvo, Natalia Fernández Núñez, Alicia Folgar Torres, Carme García Benito, Aránzazu González del Alba, María José Méndez Vidal, Aurea Molina Díaz, Ignacio Rodríguez Gómez, Sergio Vázquez Estévez

      págs. 3557-3557